Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biomedicines
|
October 27, 2022
Adapter CAR T Cell Therapy for the Treatment of B-Lineage Lymphomas
Daniel Atar, Anna-Sophia Mast, Sophia Scheuermann, et al.
Briefings in Functional Genomics
|
December 18, 2019
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies
Guillermo Ureña-Bailén, Andrés Lamsfus-Calle, Alberto Daniel-Moreno, et al.
Transplantation and Cellular Therapy
|
May 17, 2022
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation
Dominik Schneidawind, Silke Duerr-Stoerzer, Sonja Liewer, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou, et al.
Oncoimmunology
|
February 1, 2020
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
Christian M Seitz, Sarah Schroeder, Philipp Knopf, et al.
JAMA
|
June 27, 2023
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
Ann-Christin Pecher, Luca Hensen, Reinhild Klein, et al.
Science Translational Medicine
|
March 6, 2024
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, et al.
Frontiers in Immunology
|
August 9, 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
Christian Martin Seitz, Tim Flaadt, Markus Mezger, et al.
Journal for Immunotherapy of Cancer
|
May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort
Anna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Leukemia
|
August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia
Daniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biomedicines
|
October 27, 2022
Adapter CAR T Cell Therapy for the Treatment of B-Lineage Lymphomas
Daniel Atar, Anna-Sophia Mast, Sophia Scheuermann, et al.
Briefings in Functional Genomics
|
December 18, 2019
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies
Guillermo Ureña-Bailén, Andrés Lamsfus-Calle, Alberto Daniel-Moreno, et al.
Transplantation and Cellular Therapy
|
May 17, 2022
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation
Dominik Schneidawind, Silke Duerr-Stoerzer, Sonja Liewer, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou, et al.
Oncoimmunology
|
February 1, 2020
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
Christian M Seitz, Sarah Schroeder, Philipp Knopf, et al.
JAMA
|
June 27, 2023
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
Ann-Christin Pecher, Luca Hensen, Reinhild Klein, et al.
Science Translational Medicine
|
March 6, 2024
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, et al.
Frontiers in Immunology
|
August 9, 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
Christian Martin Seitz, Tim Flaadt, Markus Mezger, et al.
Journal for Immunotherapy of Cancer
|
May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort
Anna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.
Leukemia
|
August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia
Daniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Page
of 2